Haemophilia B mutations in Sweden: A population-based study of mutational heterogeneity

British Journal of Haematology

Volumn 113, Issue 1, 2001, Pages 81-86

  Ljung, Rolf ^a,d   Petrini, Pia ^b   Tengborn, Lilian ^c   Sjörin, Elsy ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Factor IX; Haemophilia B; Inhibitor; Mutation; Mutation frequency

Indexed keywords

BLOOD CLOTTING FACTOR 9;

ARTICLE; DNA POLYMORPHISM; FAMILY STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HAPLOTYPE; HEMOPHILIA B; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONSENSE MUTATION; POPULATION RESEARCH; PRIORITY JOURNAL; SWEDEN;

AGE FACTORS; CODON, NONSENSE; DATABASES, FACTUAL; FEMALE; GENE DELETION; GENETIC HETEROGENEITY; HEMOPHILIA B; HETEROZYGOTE; HUMANS; MALE; MUTATION, MISSENSE; SEX; SWEDEN;

EID: 0035022048     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02759.x     Document Type: Article

References (36)

1. Factor IX gene analysis in 70 unrelated patients with haemophilia B: Description of 13 new mutations
2. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: Family studies indicate a mutation type-dependent sex ratio of mutation frequencies
3. A new MspI restriction fragment length polymorphism in the hemophilia B locus
4. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: A Seattle series
5. The mutational spectrum of single base-pair substitutions causing human genetic disease: Patterns and predictions
6. A comparison of human prothrombin, factor IX (Christmas factro), factor X (Stuart factor) and protein S
7. Estimation of genetic risks of carriership for possible carriers of Christmas disease (hemophilia B)
8. Gene deletions in patients with haemophilia B and anti-factor IX antibodies
9. Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency)
10. Haemophilia B: Database of point mutations and short additions and deletions - Eighth edition
11. The role of genetics in inhibitor formation
12. The Malmo polymorphism of factor IX: Establishing the genotypes by rapid analysis of DNA
13. The incidence and distribution of CpG-TpG transitions in the coagulation FIX gene. A fresh look at CpG mutational hot-spots
14. Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B
15. The mutation rate of the gene for haemophilia and its segregation ratios male and females
16. Use of a BamHI polymorphism in the factor IX gene for the determination of hemophilia B carrier status
17. Nine independent F9 mutations in the Mexican hemophilia B population: Nonrandom recurrences of point mutation events in the human germline
18. Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States
19. The rates and patterns of deletions in the human factor IX gene
20. Germline origins in the human F9 gene: Frequent G:C->A:T mosaicism and increased mutations with advanced maternal age
21. Moderate haemophilia B in a female carrier caused by preferential inactivity of paternal X chromosome
22. Origin of mutation in sporadic cases of haemophilia-B
23. Gene mutations and inhibitor formation in patients with hemophilia B
24. Two factor IX mutations in the family of an isolated haemophilia B patient: Direct carrier diagnosis by amplification mismatch detection (AMD)
25. Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden
26. First report on UK database of haemophilia B mutations and pedigrees
27. Antibodies to blood coagulation factors
28. Prevalance of inhibitors in a population of 3435 hemophilia patients in France
29. Molecular biology of the hemophilias
30. Another genetic variant of haemophilia B: Haemophilia B Leyden
31. Molecular studies of haemophilia B in Sweden. Identification of patients with total deletion of the factor IX gene and without inhibitory antibodies
32. Polymorphism of normal factor IX detected by mouse monoclonal antibodies
33. Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms
34. Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers
35. Nucleotide sequence of the gene for factor IX (anti-haemophilic B)